Sunday, June 3, 2018
- 2:30pm-2:42pm
-
Introduction of Direct Acting Antivirals for HCV: Fewer Kidney Discards but a Long Way to Go
- 2:30pm-2:42pm
-
Ischemia Reperfusion Injury & Risk for Antibody Mediated Rejection (ABMR) in HLA Sensitized Patients Treated with C1 Esterase Inhibitor (C1INH)
Concurrent Session: Kidney Acute Antibody Mediated Rejection • Room Hall 4B
- 2:30pm-2:42pm
-
mTOR Inhibition with Everolimus in De Novo Living Donor Liver Transplantation – 24-Months Results from the H2307 Pivotal Trial
- 2:30pm-2:42pm
-
Potential Living Donors Identified through Social Media
Concurrent Session: Kidney Living Donor: Selection • Room 606/607
- 2:30pm-2:42pm
-
The Role of CD46 in Early Islet Engraftment in a Dual Transplant Model
Concurrent Session: Xenotransplantation • Room 602/603/604
- 2:42pm-2:54pm
-
Anti-Angiotensin II Type 1-Receptor Antibodies (AT1R-Ab) Induce a Specific Phenotype of Rejection Distinct from HLA Antibody-Mediated Rejection
Concurrent Session: Kidney Acute Antibody Mediated Rejection • Room Hall 4B
- 2:42pm-2:54pm
-
Donor-Specific B-Cell Tolerance after Successful ABO Blood Type Incompatible (ABOi) Living Donor Liver Transplantation (LDLT)
- 2:42pm-2:54pm
-
Early Blockade of Toll-Like Receptor 4 Reduces Ischemia-Reperfusion Injury and Improves Islet Transplantation Outcomes
- «Previous Page
- 1
- 2
- 3
- 4
- …
- 57
- Next Page»